One tops up the fluid. The other argues with the joint.

PRP OR GEL INJECTIONS

Hyaluronic acid injections — gel shots, viscosupplementation, sold under several brand names — are the other non-steroid option for an arthritic knee, and the one most likely to be covered by insurance. That coverage difference does more to determine what people receive than any evidence does.

What each is trying to do

Hyaluronic acid [a lubricating molecule naturally present in joint fluid] is supplementation. Arthritic joint fluid has lower molecular weight and poorer viscoelastic properties than healthy fluid, and the injection tops it up. There may also be modest anti-inflammatory and analgesic effects beyond the mechanical one.

PRP is provocation. It delivers growth factors intended to alter the joint’s biological environment — dampening catabolic signaling, influencing synovial behavior — rather than improving its lubrication directly.

One replaces a missing property. The other tries to change the process that made it go missing.

What the comparative evidence shows

Knee osteoarthritis is one of the better-studied comparisons in this whole field, and the pattern is reasonably consistent: similar results in the first few months, with PRP pulling ahead at six to twelve. Multiple meta-analyses have reached that conclusion, with the advantage most evident in younger patients and in earlier-stage disease.

The honest qualifier is that hyaluronic acid’s own evidence base is contested. Several major orthopedic bodies have declined to recommend it routinely, on the grounds that the average effect size over placebo is small. So PRP outperforming it at a year is a real finding, but the comparator is not a high bar.

Where hyaluronic acid still makes sense

• Coverage. It is frequently covered and PRP is not, which for many people is the whole decision and there is no point pretending otherwise.
• Anticoagulation or platelet disorders. Where a platelet-based treatment is unsuitable, this is not.
• Someone who has already responded to it. If a previous course worked well, repeating it is reasonable.
• Later-stage disease. Where PRP’s advantage narrows and a lubrication effect may be as much as is available.

Where PRP is the better bet

• Earlier-stage disease with joint space preserved
• Younger patients, where the advantage is most consistent in the data
• Someone who has had gel injections that helped briefly and then did less
• Someone thinking in terms of years rather than a season
• Where the metabolic drivers are being addressed alongside — PRP acts on the biological environment, and the environment is what those drivers degrade

Can they be combined?

Some clinics combine them in a single injection, and there is a plausible rationale: mechanical improvement from one, biological signaling from the other. Small studies suggest the combination may outperform either alone.

It is not our default. The evidence is early, it adds cost, and it makes it impossible to know which component helped if you improve — which matters when deciding what to do in eighteen months. Starting with one, assessing at three months, and adding on evidence is a cleaner way to learn something about your own joint.

What neither of them does

Neither regrows cartilage. Neither reverses structural disease. Neither removes the need for the strengthening work, and in a knee, quadriceps capacity remains one of the few reliably modifiable determinants of how much that joint hurts.

Both are ways of buying a window. What fills the window is the part that changes the trajectory.

How this fits the metabolic picture

A point that gets lost in comparing two injections: the joint fluid whose quality hyaluronic acid is topping up is produced by synovium, and synovium responds to the systemic inflammatory environment it sits in. In a person with visceral adiposity and insulin resistance, that environment is actively degrading fluid quality faster than any injection replaces it.

This is why the same patient can have two identical gel courses with quite different results a year apart, and why a treatment plan that only compares injectables is answering a smaller question than the one you have. The lubrication is downstream. The signaling that spoiled it is not.

Cost and coverage, plainly

Hyaluronic acid is often covered for knee osteoarthritis, subject to a payer’s criteria. PRP is not; this is a self-pay practice. We do not publish prices on this site, and we will not predict what your insurer will do — we do not bill insurance. Call and ask about your specific situation.

What is worth weighing is that a covered treatment with a small average effect and an uncovered one with a better twelve-month profile are not straightforwardly comparable on price alone.

Why the guidelines disagree with each other

Patients researching this find one professional body recommending against hyaluronic acid and another treating it as reasonable, which is confusing enough to be worth explaining.

The disagreement is mostly about what counts as a meaningful benefit rather than about the data. Trials of viscosupplementation generally do show improvement over placebo; the argument is whether the size of that improvement clears the threshold at which a patient would notice it. Groups applying a strict minimal-clinically-important-difference criterion conclude no. Groups weighing a favorable safety profile and the poverty of the alternatives conclude it is a reasonable option.

Both positions are defensible. What follows for you is that neither treatment discussed here is a certainty, and a clinic presenting either as one is overstating its hand.

The placebo question, which applies to both

Injecting anything into a knee produces improvement in a substantial share of people. Saline does it. The needle does it. The attention, the examination and the expectation all contribute, and none of that is fraudulent — the improvement is real to the person experiencing it.

It does mean two things practically. Any comparison against no treatment overstates what the injectate contributed, and the trials worth weighting are those with an injected control arm. And if the response fades at three months in a pattern that repeats, that is information: it suggests what was bought was a window rather than a change in the joint, which should redirect the plan toward the things that do change it.

What people ask about gel injections

Are gel injections better than cortisone?

Slower to act, longer-lasting, and without the cartilage concern of repeated steroid. PRP compared with cortisone.

How many hyaluronic acid injections are needed?

Depending on the product, one injection or a weekly series of three to five. What to expect.

Will insurance cover PRP if gel injections failed?

Usually not — the coverage position does not change on that basis. What non-coverage actually means.

Which lasts longer?

In most comparative data, PRP at six to twelve months. Recovery timeline.

Related reading

• PRP for knee osteoarthritis
• PRP compared with cortisone
• Not covered is not the same as unproven
• Am I a candidate?

Where the separation between these two actually appears.